FR2797588B1 - PHARMACEUTICAL FORMULATION BASED ON AMOXYCILLIN AND CLAVULANATE - Google Patents

PHARMACEUTICAL FORMULATION BASED ON AMOXYCILLIN AND CLAVULANATE

Info

Publication number
FR2797588B1
FR2797588B1 FR0010672A FR0010672A FR2797588B1 FR 2797588 B1 FR2797588 B1 FR 2797588B1 FR 0010672 A FR0010672 A FR 0010672A FR 0010672 A FR0010672 A FR 0010672A FR 2797588 B1 FR2797588 B1 FR 2797588B1
Authority
FR
France
Prior art keywords
amoxycillin
clavulanate
pharmaceutical formulation
formulation based
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0010672A
Other languages
French (fr)
Other versions
FR2797588A1 (en
Inventor
Nathalie Claude Mariann Barges
Jacky Andre Gustave Mention
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Laboratoires Pharmaceutiques
Original Assignee
SmithKline Beecham Laboratoires Pharmaceutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9919840.0A external-priority patent/GB9919840D0/en
Priority claimed from GBGB9920150.1A external-priority patent/GB9920150D0/en
Application filed by SmithKline Beecham Laboratoires Pharmaceutiques filed Critical SmithKline Beecham Laboratoires Pharmaceutiques
Publication of FR2797588A1 publication Critical patent/FR2797588A1/en
Application granted granted Critical
Publication of FR2797588B1 publication Critical patent/FR2797588B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
FR0010672A 1999-08-20 2000-08-17 PHARMACEUTICAL FORMULATION BASED ON AMOXYCILLIN AND CLAVULANATE Expired - Fee Related FR2797588B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9919840.0A GB9919840D0 (en) 1999-08-20 1999-08-20 Pharmaceutical formulation
GBGB9920150.1A GB9920150D0 (en) 1999-08-25 1999-08-25 Pharmaceuticals formulation

Publications (2)

Publication Number Publication Date
FR2797588A1 FR2797588A1 (en) 2001-02-23
FR2797588B1 true FR2797588B1 (en) 2003-08-01

Family

ID=26315870

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0010672A Expired - Fee Related FR2797588B1 (en) 1999-08-20 2000-08-17 PHARMACEUTICAL FORMULATION BASED ON AMOXYCILLIN AND CLAVULANATE

Country Status (1)

Country Link
FR (1) FR2797588B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114929A (en) * 1989-03-21 1992-05-19 Beecham Group P.L.C. Pharmaceutical formulation
JP2001512451A (en) * 1997-02-14 2001-08-21 スミスクライン・ビーチャム・ラボラトワール・ファルマソーティク Pharmaceutical formulations containing amoxicillin and clavulanate
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation

Also Published As

Publication number Publication date
FR2797588A1 (en) 2001-02-23

Similar Documents

Publication Publication Date Title
IL131201A (en) Pharmaceutical formulations comprising amoxycillin and clavulanate
KR950703566A (en) Thienodiazepine compound and its pharmaceutical use [THIENODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF]
BR1100329A (en) Compound and pharmaceutical formulation
DE69521799D1 (en) POLYMER COVERED TABLET CONTAINING AMOXICILLIN AND CLAVULANATE
DE69525148T2 (en) PHARMACEUTICAL FORMULATION
FR11C0007I2 (en) PHARMACEUTICAL COMPOSITION STABILIZED USING A BASIC AGENT
BR9500784A (en) Compound and pharmaceutical formulation
BR9504060A (en) Compound and pharmaceutical formulation
FR2740686B1 (en) STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
ATE234078T1 (en) PHARMACEUTICAL OMEPRAZOLE FORMULATION
BRPI9810519B1 (en) 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical composition comprising the same.
FR2685869B1 (en) THERAPEUTIC COMPOSITIONS BASED ON MIXED INHIBITORS OF NO SYNTHASE AND CYCLOOXYGENASE.
BR9607851B1 (en) combination and pharmaceutical formulation.
HK1043042A1 (en) Pharmaceutical formulation containing amoxycillin and clavulanate
FR2767479B1 (en) DRUG INJECTION DEVICE
BR9602915A (en) Medicines use and pharmaceutical formulation
ATE383868T1 (en) PHARMACEUTICAL FORMULATION CONTAINING MEGALATRAN AND ITS PROPHARMACEUTICALS
ITMI930582A0 (en) PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY
FI973230A0 (en) New pharmaceutical formulation
FR2742053B1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON MEQUITAZINE
FR2797588B1 (en) PHARMACEUTICAL FORMULATION BASED ON AMOXYCILLIN AND CLAVULANATE
BR9606066A (en) Compound and pharmaceutical formulation
FR2814368B1 (en) PHARMACEUTICAL PREPARATION BASED ON OXANS
DK136492D0 (en) A PHARMACEUTICAL FORMULATION

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100430